Idarubicin |
Idamycin |
Article: Idarubicin
![]() | |
| Idarubicin | |
| Systematic (IUPAC) name | |
| 9-acetyl-7-( 4-amino-5-hydroxy-6-methyl- tetrahydropyran-2-yl) oxy-6,9, 11-trihydroxy- 7,8,9,10-tetrahydrotetracene-5,12-dione | |
| Identifiers | |
| CAS number | 58957-92-9 |
| ATC code | L01DB06 |
| PubChem | 42890 |
| DrugBank | APRD00126 |
| Chemical data | |
| Formula | C26H27NO9 |
| Mol. weight | 497.494 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 97% |
| Metabolism | ? |
| Half life | 22 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. | ? |
| Legal status | |
| Routes | ? |
Idarubicin or 4-demethoxydaunorubicin is an anthracycline drug that is used in the treatment of cancer. It belongs to the family of drugs called antitumor antibiotics.
| Chemotherapeutic agents (L01) - Chemotherapy regimens |
|---|
| L01A - Alkylating agents: Cyclophosphamide | Chlorambucil | Melphalan | Mechlorethamine | Ifosfamide | Busulfan | ThioTEPA | Lomustine | Streptozocin | Temozolomide | Dacarbazine | Cisplatin | Carboplatin | Oxaliplatin | Procarbazine | Uramustine |
| L01B - Antimetabolites: Methotrexate | Pemetrexed | Fludarabine Cytarabine | Fluorouracil | Floxuridine | Gemcitabine | Capecitabine |
| L01C - Plant alkaloids: Vinblastine | Vincristine | Vinorelbine | Etoposide | Paclitaxel | Docetaxel |
| L01D - Cytotoxic/antitumour antibiotics: Anthracycline family (Doxorubicin | Daunorubicin | Epirubicin | Idarubicin | Mitoxantrone) | Bleomycin | Mitomycin | Hydroxyurea |
| L01X - Other, including Topoisomerase inhibitors: Topotecan | Irinotecan |
Categories: Medical treatment stubs | Chemotherapeutic agents

Not Signed In - 


